What is Medecor Pharma?
Founded in 2002, Medecor Pharma has established itself as a provider of high-quality nutrition products, with a strategic focus on family health and wellbeing. The company's portfolio includes a range of vitamins and supplements, notably featuring the leading branded Vitamin D3 in the U.S. market and innovative prenatal nutrition solutions. Medecor Pharma's commitment to utilizing premium ingredients and expert scientific knowledge underscores its mission to deliver effective healthcare products and support families in adopting healthier lifestyles.
How much funding has Medecor Pharma raised?
Medecor Pharma has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
Key Investors in Medecor Pharma
PPP
Public-Private Partnership
What's next for Medecor Pharma?
Operating at a significant Series B/C stage, Medecor Pharma's recent acquisition of substantial expansion capital indicates a strategic push for accelerated growth. This financing is likely earmarked for scaling production, expanding market reach, and potentially investing in research and development for new product lines. The company's established presence in the U.S. vitamin and supplement market, coupled with its focus on family health, positions it for continued advancement and increased market share.
See full Medecor Pharma company page
